We’re really pleased to be collaborating again with EyeForPharma and would like to invite you to join their efforts to bring together senior-level pharma execs, patient advocacy groups and leading healthcare expertise for discussions on the mHealth future of Pharma.
As I’ve detailed in this interview with EyeforPharma’s Robert Imonikhe the Pharmaceutical Industry faces incredible uncertainty as the lines between provider, payer and manufacturer are blurred. New business models and revenue streams are critical if pharma is to be able to survive ‘beyond the pill’.
Thankfully EyeForPharma have an unique reach into the Pharma industry and there’s no better indication of this than the influential speaker list that they’ve already confirmed for the two day meeting in September:
> Omar Ali, Formulary Development Pharmacist, Surrey & Sussex NHS Trust & ERG Panel for Cost Impact Modelling, NICE
> Baba Awopetu, European Marketing Director, Leica Microsystems
> Miles Ayling, Director of Innovation, NHS England
> Dr Junaid Bajwa, GP & NHS Fast Track Exec Programme, NHS
> Emre Basar, Medical Science Liaison Manager, Baxter
> Mike Bellis, EU Multi Channel Marketing – Senior Quality Manager, Pfizer
> Carlos Bezos Daleske, Head of Value Creation, IVF Spain
> Matthew Bonam, Project Director, Intelligent Pharmaceuticals, AstraZeneca
> Eddie Chan, Global Head of Customer Solutions & Innovation, Sanofi-Aventis
> David Doherty, Director, 3G Doctor
> Hervé Drevot, Vice President, CrossWorlds Healthcare
> Mark Duman, Non-Exec Director, Patient Information Forum
> Laurent Flouret, Senior Project Manager, Global Digital & Multichannel Marketing, Sanofi
> Nicola Fontanella, Director of Value Added Services, Pfizer
> Kaush Gandhi, International Digital Manager, Roche
> Mads Holmen, Founder, Bibblio
> Becky Hutchinson, Regional Commercial Lead EMEA Diabetes, Janssen
> Pelin Icil, Marketing Manager – Women’s Healthcare, Bayer Healthcare
> Christian Isler, Former Global Head of Product & Solution Development, Pfizer
> Felix Jackson, CEO, MedDigital
> Nikoletta Karagianni, EU Markets Champion for Hepatitis B, Bristol Myers Squibb
> Tommy Kok Annfeldt, Northern European Cialis Brand Manager, Eli Lilly
> Graham Leask, Academic, Aston University
> Rick Lee, Former CEO, Healthrageous Inc
> Mario Giulio Levrero, Director, Global Healthcare Providers & Market Access, Vifor Pharma
> Soeren Mattke, Managing Director, RAND
> Francois Meyer, Advisor to the President & Director, Haute Autorité de Santé
> Paul Midgley, Patient Leader, NHS England Derbyshire Nottinghamshire Area Team and Director, NHS Insights
> Marco Mohwinckel, Global Head of Integrated Care Solutions, Janssen Healthcare Innovation
> Michael Morgan-Curran, Global Director of mHealth, Personal Connected Health Alliance
> Philippe Mougin, Director of Public Affairs, Bayer France
> Julie O’Donnell, Global Head of Digital Interaction Management, Lundbeck
> Irina Osovskaya, Digital Manager, Janssen
> Samuel Pygall, Innovation Lead Associate Director, MSD
> Kay Rispeter, Associate Director Multichannel Marketing, MSD
> Michael Seres, i-Patient
> Dr Julian Spinks, General Practitioner, NHS
> Andrew Stainthorpe, Market Access Expert
> Paul Sutton, Director of Outcomes, Quintiles Commercial UK
> Matthew Thomas, Vice President Spine, Medtronic
> Albert van Eijk, Director of Oncology, Boehringer Ingelheim
> Francis White, EU General Manager, AliveCor
> Tim White, Senior Director and Head of Global Customer Interaction Management, Lundbeck
> Stephen Whitehead, CEO, Association of British Pharmaceutical Industry
Industry insights into the mHealth future of Pharma
To help ignite the discussions we’ve been working with EyeForPharma to produce and share the different outlooks of key industry participants. The first effort in this is a series of video interviews with mHealth industry leaders in which I try to get answers on the following questions:
> How do you think mHealth solutions can provide payers and physicians with a better understanding of patient experience?
> What are the benefits of this for the pharma industry?
> How do you engage both payers and clinicians on mHealth services?
> What´s the place of ´intelligent pharmaceuticals´ in the future of the industry?
> Is a disease-specific focus necessary or are there lessons that can be spread across multiple therapeutic areas?
> What comes first — the product or the outcome?
> Do you think things would have been different if Samsung, for example, had made a bid for AstraZeneca rather than Pfizer? In the future, will pharma companies be competing with mobile organisations?
_________________________________________________________
The series begins with @GoogleSunglass wearing Dr Gerard Crotty, Consultant Haemotologist & President of the Irish Hospital Consultants Association:
Next up is an interview with Google Explorer Trauma Surgeon Dr Raphael Grossmann MD FACS (a big hero of mine):
If you would like more information about the event and exclusive first access to the rest of these video interviews simply complete the following form with your contact details:
Alternatively get in touch with Aidan Brain the event Director at EyeForPharma directly on +442073757513 or email [email protected]
*** UPDATE 17 September 2014 UPDATE ***
The Slidedeck from my presentation: